Effect of P2Y12 Inhibitors on Plasma Metabolomic Changes in Patients with Acute Myocardial Infarction

被引：0
|
作者：
Eyileten, Ceren
Wicik, Zofia
Koutentakis, Michail
Gasecka, Aleksandra
Siller-Matula, Jolanta
Postula, Marek
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4139864
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4139864
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [22] How does diabetes mellitus influence prognosis of patients with acute myocardial infarction treated with primary angioplasty and potent p2y12 inhibitors
    Simek, S.
    Motovska, Z.
    Hlinomaz, O.
    Miklik, R.
    Hromadka, M.
    Knot, J.
    Varvarovsky, I.
    Dusek, J.
    Jarkovsky, J.
    Kala, P.
    Rokyta, R.
    Tousek, F.
    Majtan, B.
    Branny, M.
    Widimsky, P.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2224 - 2224
  • [23] Comparison of Short-Term Clinical Outcomes Between New P2Y12 Receptor Inhibitors and Clopidogrel in Patients with Acute Myocardial Infarction
    Park, Keun-Ho
    Jeong, Myung-Ho
    Sim, Doo Sun
    Hong, Young Joon
    Kim, Ju Han
    Ahn, Young-Keun
    Ahn, Taehoon
    Seung, Ki-Bae
    Oh, Dong Joo
    Kim, Hyo-Soo
    Gwon, Hyeon-Cheol
    Seong, In-Whan
    Chae, Shung Chull
    Kim, Kwon-Bae
    Kim, Young Jo
    Cha, Kwang Soo
    Oh, Seok Kyu
    Chae, Jei Keon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (17) : S10 - S10
  • [24] The Comparative Effectiveness of Potent P2Y12 Inhibitors Versus Clopidogrel in Patients with Acute Myocardial Infarction Undergoing PCI: National Registry Data
    Lukacs, Reka Aliz
    Tornyos, Daniel
    Kupo, Peter
    Janosi, Andras
    Komocsi, Andras
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [25] Importance of potent P2Y12 receptor blockade in acute myocardial infarction: focus on prasugrel
    Jeong, Young-Hoon
    Tantry, Udaya S.
    Gurbel, Paul A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (12) : 1771 - 1796
  • [26] P2Y12 is involved in emergency hematopoiesis after myocardial infarction
    Seung, H.
    Wadle, C.
    Hopp, T.
    Duerschmied, D.
    Hilgendorf, I.
    Wolf, D.
    Stachon, P.
    Bode, C.
    Von Zur Muehlen, C.
    Heidt, T.
    EUROPEAN HEART JOURNAL, 2018, 39 : 694 - 694
  • [27] New P2Y12 inhibitors
    Storey, Robert F.
    HEART, 2011, 97 (15) : 1262 - 1267
  • [28] THE EFFECT OF CESSATION OF 2ND GENERATION P2Y12 INHIBITOR THERAPY ON PLATELET REACTIVITY IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION
    Witberg, Guy
    Bathish, Jalal
    Solodky, Alejandro
    Bental, Tamir
    Kornowski, Ran
    Lev, Eli
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 73 - 73
  • [29] Utilization of P2Y12 Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and Frailty
    Ko, Darae
    Pande, Ashvin
    Lin, Kueiyu Joshua
    Cervone, Alexander
    Bessette, Lily G.
    Lee, Su Been
    Cheng, Susan
    Glynn, Robert J.
    Kim, Dae Hyun
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 207 : 245 - 252
  • [30] Bending the Reluctance of No Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction
    Koliastasis, Leonidas
    Doundoulakis, Ioannis
    Xaplanteris, Panagiotis
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (06)
12345